Commentary: Tacrolimus in the Treatment of Chronic and Refractory Late-Onset Immune-Mediated Adverse Effects Related to Silicone Injections


  • The author has indicated no significant interest with commercial supporters.

Address correspondence and reprint requests to: David M. Duffy, MD, Department of Dermatology, University of Southern California, 4201 Torrance Blvd., suite 710, Torrance, CA, 90503, or e-mail:

No abstract is available for this article.